Race Joint Venture With TargImmune

2017-10-11T16:28:31+02:00

Race Oncology Limited (ASX: RAC) announced today that it has executed a Letter of Intent with TargImmune Therapeutics AG (Basel, Switzerland) to enter into a joint venture between the two companies. Race Joint Venture With TargImmune MELBOURNE, Australia, July 10, 2017 Race Oncology Limited [...]